Rheumatology
Reactive Arthritis
Post-infectious asymmetric oligoarthritis — GU / GI trigger, NSAIDs, address infection, screen STI.
Source: EULAR; GUM
Step 1 of ~3
info
Recognise
Asymmetric oligoarthritis (lower limb predominant) within 6 weeks of GU (Chlamydia trachomatis) or GI (Salmonella, Shigella, Campylobacter, Yersinia) infection. Triad — Reiter's: arthritis + urethritis + conjunctivitis (only 30% of cases). Other: enthesitis, dactylitis, oral ulcers, balanitis circinata, keratoderma blennorrhagicum (psoriasis-like rash on soles), nail dystrophy. HLA-B27 positive ~50%.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Clopidogrel (ACS / Post-PCI) · Antiplatelet / ACS
- Hydroxychloroquine · Aminoquinoline — Malaria Prophylaxis / SLE / Rheumatoid Arthritis
- Human Chorionic Gonadotrophin (hCG) · Gonadotrophin (Ovulation Trigger)
- Diclofenac (Dysmenorrhoea / Post-gynaecological Procedure) · NSAID — Gynaecological Pain
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only. Always apply local guidelines and clinical judgement.